Human embryonic stem cell-derived cells rescue visual function in dystrophic RCS rats.

@article{Lund2006HumanES,
  title={Human embryonic stem cell-derived cells rescue visual function in dystrophic RCS rats.},
  author={Raymond D. Lund and Shaomei Wang and Irina V. Klimanskaya and Toby M. Holmes and Rebeca Ramos-Kelsey and Bin Lu and S. V. Girman and Nicholas Bischoff and Yves Sauve and Robert Lanza},
  journal={Cloning and stem cells},
  year={2006},
  volume={8 3},
  pages={
          189-99
        }
}
Embryonic stem cells promise to provide a well-characterized and reproducible source of replacement tissue for human clinical studies. An early potential application of this technology is the use of retinal pigment epithelium (RPE) for the treatment of retinal degenerative diseases such as macular degeneration. Here we show the reproducible generation of RPE (67 passageable cultures established from 18 different hES cell lines); batches of RPE derived from NIH-approved hES cells (H9) were… 

Figures and Tables from this paper

Human embryonic stem cell-derived retinal pigment epithelial cell transplantation for retinal degeneration

Promising results suggest that hESC-derived RPE cells could represent a novel treatment paradigm for retinal degenerations hallmarked by tissue loss or dysfunction.

Protective Effects of Human iPS-Derived Retinal Pigment Epithelium Cell Transplantation in the Retinal Dystrophic Rat

It is demonstrated that iPS cells can be differentiated into functional iPS-RPE and that transplantation of these cells can facilitate the short-term maintenance of photoreceptors through phagocytosis ofPhotoreceptor outer segments.

Cells Isolated from Umbilical Cord Tissue Rescue Photoreceptors and Visual Functions in a Rodent Model of Retinal Disease

Since the umbilical tissue‐derived cells demonstrated the best photoreceptor rescue and, unlike mesenchymal stem cells, were capable of sustained population doublings without karyotypic changes, it is proposed that they may provide utility as a cell source for the treatment of retinal degenerative diseases such as retinitis pigmentosa.

Human embryonic stem cells for retinal repair : preclinical in vitro and in vivo studies for the treatment of age-related macular degeneration with human embryonic stem cell-derived retinal pigment epithelial cells

Evidence is shown that allogeneic replacement therapy using subretinal injection of hESC-RPE in suspension can be a successful treatment if (i) the derived cells retain native RPE cell properties; (ii) the cells are transplanted early enough so theSubretinal milieu supports their integration; and (iii) the Cells can be engineered so that they can evade the host immune system and consequent graft rejection.

Differentiation of Human Embryonic Stem Cells and Human Induced Pluripotent Stem Cells into Retinal Pigment Epithelium

Improvements are needed to increase the yield and purity of the RPE cultures in order to reach sufficient amount of maturated cells with RPE characteristics, which can be utilized safely in therapeutic use.

Enhanced functional integration of human photoreceptor precursors into human and rodent retina in an ex vivo retinal explant model system.

The utility of an ex vivo model system to define factors, such as TSP-1, which could influence integration efficiency in future in vivo experiments in models of retinal degeneration are demonstrated.

RPE and Stem Cell Therapy

Two RPE cell transplantation strategies—each with their own pros and cons—are currently under development: injection of a single-cell suspension, and transplantation of intact RPE sheet with or without a biomaterial-based scaffold.

Utilizing stem cell-derived RPE cells as a therapeutic intervention for age-related macular degeneration.

Work reported by several groups, including the own, that clearly demonstrate that transplanted RPE cells can provide anatomical and functional photoreceptor rescue in animal models of retinal degeneration are summarized.

Transplantation of Human Embryonic Stem Cell-Derived Retinal Pigment Epithelium for the Treatment of Macular Degeneration

In the first ever clinical trial of subretinal hESC-RPE transplantation in humans, no adverse events related to the treatment, such as hyperproliferation, tumorigenicity, inflammation, infection, or rejection, were noted in either patient.
...

References

SHOWING 1-10 OF 34 REFERENCES

Subretinal transplantation of genetically modified human cell lines attenuates loss of visual function in dystrophic rats

  • R. LundP. Adamson J. Greenwood
  • Biology, Medicine
    Proceedings of the National Academy of Sciences of the United States of America
  • 2001
The efficacy of subretinal transplantation of two independent human RPE cell lines each exhibiting genetic modifications that confer long-term stability in vitro are examined to demonstrate the potential of genetically modified human R PE cells for ultimate application in therapeutic transplantation strategies for retinal degenerative diseases caused by RPE dysfunction.

Derivation and comparative assessment of retinal pigment epithelium from human embryonic stem cells using transcriptomics.

A differentiation system that does not require coculture with animal cells or factors is described, thus allowing the production of zoonoses-free RPE cells suitable for subretinal transplantation in patients with retinal degenerative diseases.

Embryonic Stem Cells: Potential Source for Ocular Repair

This review focuses on reproducible and efficient differentiation methods for the generation of lens cells, retinal neurons, and retinal pigment epithelial cells from ES cells, which are expected to alleviate the problem of the shortage of donor cells for cell-replacement therapy.

Retinal Incorporation and Differentiation of Neural Precursors Derived from Human Embryonic Stem Cells

The results suggest that hESCs have the potential to differentiate into retinal cells and that the subretinal microenvironment supports their differentiation toward a photoreceptor fate.

In vitro and in vivo characterization of pigment epithelial cells differentiated from primate embryonic stem cells.

The ESPEs had morphologic and physiological properties of normal RPE cells, and these findings suggest that these cells may provide an unlimited source of primate cells to be used for the study of pathogenesis, drug development, and cell-replacement therapy in eyes with retinal degenerative diseases due to primary RPE dysfunction.

Photoreceptor repair in response to RPE transplants in RCS rats: Outer segment regeneration

This study investigated the photoreceptor rescue effects in RCS rats within the first three weeks following transplantation in an attempt to determine if RPE transplants initiate repair mechanisms, specifically, outer segment (OS) regeneration.

Transplanted human embryonic germ cell‐derived neural stem cells replace neurons and oligodendrocytes in the forebrain of neonatal mice with excitotoxic brain damage

It is concluded that human EG cell‐derived NSCs can engraft successfully into injured newborn brain, where they can survive and disseminate into the lesioned areas, differentiate into neuronal and glial cells, and replace lost neurons.

Transplantation of Schwann cell line clones secreting GDNF or BDNF into the retinas of dystrophic Royal College of Surgeons rats.

This study demonstrates that ex vivo gene therapy and subsequent cell transplantation can be effective in preserving photoreceptors from the cell death that normally accompanies retinal degeneration.

Morphological changes in the Royal College of Surgeons rat retina during photoreceptor degeneration and after cell‐based therapy

After introducing a retinal pigment epithelial cell line to the subretinal space early in the progress of photoreceptor degeneration, most inner retinal changes were held in abeyance for up to at least 10 months of age, an encouraging finding.